Clinical Trials Logo
  1. Home
  2. Helicobacter Infections
  3. NCT02449941
  4. Details
NCT02449941 Clinical Trial

Helicobacter Pylori and Proton Pump Inhibitor

Helicobacter Infections Clinical Trial

Official title:
Distribution of Helicobacter Pylori According to the Use of Proton Pump Inhibitor

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02449941
Other study ID # 2014-0341
Secondary ID
Status Completed
Phase N/A
First received May 14, 2015
Last updated December 4, 2016
Start date March 2014
Est. completion date December 2016

Study information
Verified date December 2016
Source Asan Medical Center
Contact n/a
Is FDA regulated No
Health authority Korea: Ministry of Food and Drug Safety
Study type Observational

Clinical Trial Summary

The purpose of this study is to know the distribution of HP in stomach before use of PPI, during use of PPI, and after stop of PPI.

Description:

Endoscopy and biopsy will be performed to investigate the distrubition of HP before, during, and after using PPI.

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria:

1. Patients who are indicated to endoscopic resection due to gastric neoplasm

2. Aged between 19 to 65 years

3. Informed consent

Exclusion Criteria:

1. Previous history of HP eradication

2. Previous history of PPI use within 6 months

3. No HP infection

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Drug:
• PPI (proton pump inhibitor)
Pre ESD (endoscopic submucosal dissection) Assessment atrophy and metaplasia in stomach, Check Helicobacter pylori Use of PPI for 2 months Post ESD 1 (After 2 months) Assess the distribution of helicobacter pylori after using PPI. Stop of PPI Post ESD 2 (After 4 months) Assess the distribution of helicobacter pylori after stop of PPI.

Locations
Country Name City State
Korea, Republic of Asan Medical Center Seoul Songpa-gu

Sponsors (1)
Lead Sponsor Collaborator
Asan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Analysis the change of Helicobacter pylori distribution according to the use of proton pump inhibitor Change in the distribution of Helicobacter Pylori(HP) at 4 months. Yes
Secondary Analysis the change of HP distribution according to the use of PPI in atrophic change of stomach Change in the distribution of Helicobacter Pylori(HP) at 4 months. Yes
See also
  Status Clinical Trial Phase
Completed NCT00723502 - Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients Phase 2
Recruiting NCT03365609 - A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children N/A
Completed NCT00005496 - Inflammation, Infection, and Future Cardiovascular Risk N/A
Completed NCT01219764 - A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection Phase 4
Completed NCT00216450 - Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. Phase 4
Completed NCT00212225 - Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) N/A
Completed NCT00083291 - Helicobacter Pylori and Dry Eye N/A
Not yet recruiting NCT04652284 - Effectiveness of Rifabutin for Treatment of Helicobacter Pylori Phase 3
Completed NCT02395458 - Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens Phase 4
Completed NCT00194688 - Breath Ammonia Method for H. Pylori Detection: Phase II Phase 2
Not yet recruiting NCT02126722 - Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy N/A
Active, not recruiting NCT01133951 - Helicobacter Pylori Eradication to Prevent Gastric Cancer N/A
Completed NCT00669955 - Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy Phase 3
Completed NCT00816140 - Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication Phase 4
Completed NCT00490386 - Helicobacter Pylori and Acute Alcohol Induced Pancreatitis N/A
Withdrawn NCT02645201 - The Effect of Probiotic Combination on Helicobacter Pylori Infection in Children N/A
Terminated NCT00664209 - Treating H. Pylori in Parkinson's Patients With Motor Fluctuations Phase 3
Completed NCT01922505 - Eradication Rates of Helicobacter Pylori and Its Affecting Factors Phase 4
Completed NCT01792700 - Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Phase 4
Completed NCT02970110 - Specimen Collection Study for H. Pylori Testing